+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
ID07548346

REVIVE-CVST Trial Comparing Endovascular Thrombectomy Plus Standard Anticoagulation Versus Anticoagulation Alone in Adults with Severe Cerebral Venous Sinus Thrombosis in the Middle East and North Africa Region

Led by Middle East North Africa Stroke and Interventional Neurotherapies Organization · Updated on 2026-10-21

440

Participants Needed

14

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether early endovascular thrombectomy EVT combined with standard anticoagulation improves outcomes compared to anticoagulation alone in adults with severe cerebral venous sinus thrombosis CVST. This multicenter, randomized, open-label trial focuses on patients aged 18 to 65 presenting within 14 days of symptom onset with imaging-confirmed CVST and markers of severity, aiming to address the lack of strong evidence for EVT in this condition, especially in the Middle East, North Africa, and South Asia regions. Participants are randomly assigned to one of two groups the intervention arm receiving EVT within 24 hours plus standard anticoagulation, and the control arm receiving anticoagulation alone. EVT techniques include mechanical thrombectomy, aspiration, or balloon-assisted methods. Anticoagulation consists of intravenous heparin or low-molecular-weight heparin followed by oral anticoagulants for 3-12 months. The study spans approximately 42 months, with 18 months for enrollment and 12 months follow-up for the last patient. Participants will undergo assessments at 30, 90, and 180 days after randomization, including clinical evaluations like the modified Rankin Scale and NIH Stroke Scale, quality of life questionnaires, cognitive testing, and imaging at 90 days. Researchers will monitor functional independence at 12 months as the primary outcome, along with secondary outcomes such as recanalization rates, mortality, clinical improvement timing, quality of life, cognitive function, and seizure frequency. Safety is overseen by an independent board with interim analyses planned throughout enrollment.

CONDITIONS

Brief Title

MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here